NCT00258128View on ClinicalTrials.gov

Effect of Salicylate on Glucose Metabolism in Insulin Resistance States

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Insulin Resistance
Interventions
DRUG

Salsalate

Active

DRUG

Placebo

Placebo for salslate, used only in the third trial

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Joslin Diabetes Center

OTHER

NCT00258128 - Effect of Salicylate on Glucose Metabolism in Insulin Resistance States | Biotech Hunter | Biotech Hunter